TNF and rheumatoid arthritis: It was shown recently that therapeutic anti-TNF antibody Infliximab binds to and promotes the expression of membrane bound TNF on monocytes from RA patients, and consequently enhances Treg activity through TNF-TNFR2 interaction (Chen and Oppenheim, 2016; Nguyen and Ehrenstein, 2016).